← Back to Clinical Trials
Recruiting NCT07113873

NCT07113873 Patient Satisfaction and Clinical Performance of Ultra-translucent Multi-layer Monolithic Zirconia and Lithium Disilicate Ceramic Laminate Veneers. Randomized Control Clinical Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07113873
Status Recruiting
Phase
Sponsor Cairo University
Condition Ultra Translucent Zirconia
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2025-06-02
Primary Completion 2026-01-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
ultra-translucent monolithic multi layered zirconialithium disilcate ceramics

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2025-06-02 with a primary completion date of 2026-01-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Despite of the improved esthetics of ultra-translucent zirconia, bonding between resin cement and zirconia is difficult to achieve because of their chemical inertness and lack of silica content. However, the effect of the bond strength with the new generation of high-translucent zirconia materials is not clear and further studies are needed. Kongkiatkamon, Suchada et al., (2023) The long-term bond strength of cubic zirconia was similar to 3Y-TZP zirconia and lithium disilicate ceramics and showed sufficient bond strength. A 5-mol% yttria-stabilized tetragonal Zr polycrystal showed high shear bond strength similar to Li disilicate glass-ceramic. Air blasting of Zr followed by primers and resin cements based on 10-MDP monomer has proven its efficiency in Zr-resin bonding. Both ultra-translucent 5Y-PSZ Zr and Li disilicate offer viable options for esthetic restorations on anterior teeth Adak et al. (2023),Elsisi et al. (2024) Currently, there is a lack of reports in the literature regarding the long-term clinical performance of ultra-translucent zirconia, especially considering its use in manufacturing monolithic veneers. Therefore, the purpose of the present clinical trial is to assess the validity of using ultra-translucent multi-layer zirconia ceramic veneer as an alternative to lithium disilicate ceramic veneer

Eligibility Criteria

Inclusion Criteria: 1- Age between 18 and 50 years. 2. Absence of abnormal functional habits such as bruxism. 3. Good condition of gingival and periodontal tissues. 4. Good oral health. 5. A clear indication for patients for treatment with ceramic laminate veneers: Presence of diastema, moderate discolored dental restorations, slight modification of color in the discolored teeth, and modification of shape and sizes of the teeth. 6\. Patient commitment for attending follow up session Exclusion Criteria: 1. Age under 18 years 2. Bad oral hygiene 3. Dysfunctional habits and bruxism 4. Periodontal diseases 5. High risk of caries 6. Inadequate enamel for bonding 7. Extreme staining and color change in tooth -

Contact & Investigator

Central Contact

Gihan El naggar Professor, PhD

✉ gihan.abdelhadyelnaggar@dentistry.cu.edu.eg

📞 01117676668

Frequently Asked Questions

Who can join the NCT07113873 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Ultra Translucent Zirconia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07113873 currently recruiting?

Yes, NCT07113873 is actively recruiting participants. Contact the research team at gihan.abdelhadyelnaggar@dentistry.cu.edu.eg for enrollment information.

Where is the NCT07113873 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07113873 clinical trial?

NCT07113873 is sponsored by Cairo University. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology